Nanobiotix Future Growth

Nanobiotix is forecast to grow earnings and revenue by 21.6% and 17.6% per annum respectively while EPS is expected to grow by 22.2% per annum.

21.6%

Earnings growth rate

22.2%

EPS growth rate

No updates

Earnings and Revenue Growth Forecasts

BATS-CHIXE:NANOP - Analysts future estimates and past financials data (EUR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	19	-45	-38	-40	4
12/31/2024	31	-26	-10	-18	5
12/31/2023	26	-41	-42	-4	3
6/30/2023	7	-59	-37	-37	N/A
3/31/2023	6	-58	-37	-37	N/A
12/31/2022	5	-57	-37	-37	N/A
9/30/2022	4	-50	-35	-35	N/A
6/30/2022	3	-43	-33	-32	N/A
3/31/2022	3	-45	-31	-31	N/A
12/31/2021	3	-47	-30	-30	N/A
9/30/2021	2	-45	-30	-30	N/A
6/30/2021	2	-43	-30	-30	N/A
3/31/2021	2	-39	-29	-29	N/A
12/31/2020	2	-34	-28	-28	N/A
9/30/2020	2	-41	-31	-30	N/A
6/30/2020	2	-48	-33	-33	N/A
3/31/2020	2	-49	-38	-37	N/A
12/31/2019	3	-51	-43	-41	N/A
9/30/2019	3	-46	-38	-37	N/A
6/30/2019	3	-42	-34	-33	N/A
3/31/2019	3	-36	-30	-30	N/A
12/31/2018	3	-30	-26	-26	N/A
9/30/2018	4	-28	-25	-24	N/A
6/30/2018	4	-27	-24	-22	N/A
3/31/2018	4	-26	-23	-22	N/A
12/31/2017	4	-26	-22	-21	N/A
9/30/2017	4	-25	-21	-20	N/A
6/30/2017	4	-24	-19	-19	N/A
3/31/2017	5	-23	N/A	-19	N/A
12/31/2016	5	-22	N/A	-18	N/A
9/30/2016	5	-21	N/A	-19	N/A
6/30/2016	5	-19	N/A	-20	N/A
3/31/2016	5	-18	N/A	-19	N/A
12/31/2015	4	-17	N/A	-17	N/A
9/30/2015	4	-15	N/A	-15	N/A
6/30/2015	3	-13	N/A	-12	N/A
3/31/2015	3	-11	N/A	-11	N/A
12/31/2014	3	-10	N/A	-9	N/A
9/30/2014	2	-9	N/A	-8	N/A
6/30/2014	2	-8	N/A	-8	N/A
3/31/2014	2	-8	N/A	-7	N/A
12/31/2013	2	-8	N/A	-7	N/A
9/30/2013	1	-8	N/A	-6	N/A
6/30/2013	1	-7	N/A	-5	N/A
3/31/2013	1	-6	N/A	-4	N/A
12/31/2012	1	-5	N/A	-4	N/A

Earnings vs Savings Rate: NANOP is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: NANOP is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: NANOP is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: NANOP's revenue (17.6% per year) is forecast to grow faster than the UK market (4% per year).

High Growth Revenue: NANOP's revenue (17.6% per year) is forecast to grow slower than 20% per year.

Future ROE: Insufficient data to determine if NANOP's Return on Equity is forecast to be high in 3 years time